Frontiers Healthcare Services (FHS) has publicly disputed recent corruption allegations surrounding its management of the Airport COVID-19 testing program, labeling the accusations as unfounded and politically motivated fabrications.
Contract Award and Execution:
FHS emphasized its instrumental role in resuming international travel amid the pandemic, providing innovative, rapid screening at Ghana’s air borders. The company was pivotal in deploying resources urgently and globally unprecedented, with a dedicated approach to curbing the virus’s spread via travel.
Despite the politically charged criticism, FHS detailed its proactive response, investing in advanced testing machinery, facilitating efficient travel, and pioneering rapid testing for arriving passengers in Ghana as of September 1, 2020.
Efficiency and Quality Assurance:
The company utilized a sophisticated Automated Immunoassay System, vouched for by Ghana’s Food and Drugs Authority and the National Covid-19 Task Force. Notably, independent research highlighted the system’s remarkable accuracy, proving crucial in the nation’s defense against the pandemic.
FHS’s rigorous operation involved over 500 staff, ensuring round-the-clock efficient service. The state-of-the-art infrastructure could process approximately 2,100 samples hourly, a capacity unmatched globally, contradicting detractors’ underestimation of the system’s complexity.
Test Pricing Justification:
Addressing contentions over the $150 test cost, FHS cited extensive overheads, including high-grade equipment, staff welfare, and logistical needs, defending the fee as reasonable. The pricing was particularly justified given the uncertainties of the pandemic’s duration, ensuring operational sustainability.
Government Relations and Contractual Integrity:
Refuting notions of financial exploitation, FHS clarified its contract with the Ghanaian government, ensuring transparency and mutual benefit. The agreement prioritized public health over profit, contradicting claims of government shortchanging. Additionally, FHS’s investment bolstered employment and did not entail government funding, further dismissing notions of biased financial gain.
Denial of Government Favoritism:
FHS sternly denied allegations of preferential government treatment, terming such claims malicious and unfounded. The company maintained its operational independence, challenging accusers to substantiate their claims.
Conclusive Stance:
FHS concluded by asserting its significant contribution during the health crisis, regretting the political tarnishing of its efforts. The company praised its workforce’s dedication, contrasting the situation in countries facing healthcare personnel attrition. It ended with a call for recognition of genuine national contributors, rebuking those spreading slander for political points.
